amlodipine has been researched along with Coronary Thrombosis in 4 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
Coronary Thrombosis: Coagulation of blood in any of the CORONARY VESSELS. The presence of a blood clot (THROMBUS) often leads to MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The study was a randomized controlled trial of 2 antihypertensives (amlodipine and enalapril) compared with placebo in patients with coronary artery disease and diastolic blood pressure less than 100 mm Hg." | 5.16 | Relationship of antihypertensive treatment to plasma markers of vascular inflammation and remodeling in the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis study. ( Ganz, P; Kinlay, S; Libby, P; Nicholls, SJ; Nissen, SE; Rifai, N; Sutradhar, SC; Zamani, P, 2012) |
| "Only amlodipine was associated with clopidogrel poor-response." | 1.36 | The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response. ( Breet, NJ; de Boer, A; Deneer, VH; Hackeng, CM; Harmsze, AM; Klungel, OH; Robijns, K; Ruven, HJ; Ten Berg, JM; van Werkum, JW, 2010) |
| "completely abolished the experimental coronary thrombosis and prevented the exacerbation of coronary thrombosis by epinephrine 0." | 1.30 | Inhibition of platelet activity in vivo by amlodipine alone and combined with aspirin. ( Folts, JD, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harmsze, AM | 1 |
| Robijns, K | 1 |
| van Werkum, JW | 1 |
| Breet, NJ | 1 |
| Hackeng, CM | 1 |
| Ten Berg, JM | 1 |
| Ruven, HJ | 1 |
| Klungel, OH | 1 |
| de Boer, A | 1 |
| Deneer, VH | 1 |
| Zamani, P | 1 |
| Ganz, P | 1 |
| Libby, P | 1 |
| Sutradhar, SC | 1 |
| Rifai, N | 1 |
| Nicholls, SJ | 1 |
| Nissen, SE | 1 |
| Kinlay, S | 1 |
| Mehta, JL | 1 |
| Folts, JD | 1 |
1 trial available for amlodipine and Coronary Thrombosis
| Article | Year |
|---|---|
Relationship of antihypertensive treatment to plasma markers of vascular inflammation and remodeling in the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis study.
Topics: Amlodipine; Antihypertensive Agents; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Corona | 2012 |
3 other studies available for amlodipine and Coronary Thrombosis
| Article | Year |
|---|---|
The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response.
Topics: Aged; Amlodipine; Angioplasty; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Platel | 2010 |
Emerging options in the management of myocardial ischemia.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angina Pectoris; Calcium Channel Blockers; Coronary Disease | 1994 |
Inhibition of platelet activity in vivo by amlodipine alone and combined with aspirin.
Topics: Amlodipine; Animals; Aspirin; Blood Flow Velocity; Blood Platelets; Calcium Channel Blockers; Corona | 1997 |